mRNA |
Imatinib |
FIMM |
pan-cancer |
AAC |
0.042 |
0.8 |
mRNA |
PF-750 |
CTRPv2 |
pan-cancer |
AAC |
0.0082 |
0.8 |
mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
-0.008 |
0.8 |
mRNA |
erismodegib |
CTRPv2 |
pan-cancer |
AAC |
-0.008 |
0.8 |
mRNA |
Cisplatin |
GDSC1000 |
pan-cancer |
AAC |
0.0072 |
0.8 |
mRNA |
BRD-K14844214 |
CTRPv2 |
pan-cancer |
AAC |
-0.0081 |
0.8 |
mRNA |
BRD-K52037352 |
CTRPv2 |
pan-cancer |
AAC |
0.0084 |
0.8 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.8 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0076 |
0.8 |
mRNA |
ciclosporin |
CTRPv2 |
pan-cancer |
AAC |
-0.0078 |
0.8 |